Ameritas Investment Partners, Inc. Journey Medical Corp Transaction History
Ameritas Investment Partners, Inc.
- $3.05 Billion
- Q2 2025
A detailed history of Ameritas Investment Partners, Inc. transactions in Journey Medical Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 1,239 shares of DERM stock, worth $10,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,239Holding current value
$10,060% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DERM
# of Institutions
62Shares Held
7MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$15.1 Million0.8% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.15MShares$9.35 Million0.04% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$7.02 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA565KShares$4.59 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA262KShares$2.13 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $94.2M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...